HB 2386 Drug Take-Back Program

HB 2386 VOTE: NO
In Committee
Public Hearing 03/06/2017 3:00pm HR E
Status (cverview) of bill:https://olis.leg.state.or.us/liz/2017R1/Measures/Overview/HB2386
Committee assigned to bill:https://olis.leg.state.or.us/liz/2017R1/Committees/HHC/Overview


Bill Published on Track Their Vote HERE

This bill requires manufacturers of certain types of drugs to collect unused drugs following a plan that they develop by 12-31-18 but program becomes effective 1-1-18

Personal Choice and Responsibility
There is no personal choice in this action but places the total responsibility of performing the action upon the manufacturer.

Fiscal Responsibility
There is no fiscal responsibility within this bill as all costs associated with this action us bared by the manufacturers when there is no other industry that has this kind of requirement.

Limited Government
The government is attempting to control excess drugs of certain types through targeting the manufacturers rather than those directly responsible for the original issuance of the product.

Free Markets
The state is interfering with the free market by attempting to control a problem from the back door.

Leave a Reply

Time limit is exhausted. Please reload the CAPTCHA.